Cargando…

New options for the management of chronic hyperkalemia

Hyperkalemia is a frequently detected electrolyte abnormality that can cause life-threatening complications. Hyperkalemia is most often the result of intrinsic (decreased glomerular filtration rate; selective reduction in distal tubule secretory function; impaired mineralocorticoid activity; and met...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fried, Linda, Kovesdy, Csaba P., Palmer, Biff F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341013/ https://www.ncbi.nlm.nih.gov/pubmed/30675431 http://dx.doi.org/10.1016/j.kisu.2017.09.001

Ejemplares similares

New Treatment Options for Hyperkalemia in Patients with Chronic Kidney Disease
por: Esposito, Pasquale, et al.
Publicado: (2020)

Management of Chronic Hyperkalemia in Patients With Chronic Kidney Disease: An Old Problem With News Options
por: Morales, Enrique, et al.
Publicado: (2021)

Real-World Evaluation of Patiromer for the Treatment of Hyperkalemia in Hemodialysis Patients
por: Kovesdy, Csaba P., et al.
Publicado: (2018)

Hyperkalemia in Chronic Kidney Disease: Links, Risks and Management
por: Sarnowski, Alexander, et al.
Publicado: (2022)

An international Delphi consensus regarding best practice recommendations for hyperkalaemia across the cardiorenal spectrum
por: Burton, James O., et al.
Publicado: (2022)

Pathogenesis, diagnosis and management of hyperkalemia
por: Lehnhardt, Anja, et al.
Publicado: (2010)

Management of hyperkalemia in the acutely ill patient
por: Dépret, François, et al.
Publicado: (2019)

Current Management of Hyperkalemia in Patients on Dialysis
por: Bansal, Shweta, et al.
Publicado: (2020)

Chronic urticaria: new management options
por: Greenberger, Paul A
Publicado: (2014)

Renal Tubular Acidosis and Management Strategies: A Narrative Review
por: Palmer, Biff F., et al.
Publicado: (2020)

Pharmacologic Treatment of Chronic Hyperkalemia in Patients with Chronic Kidney Disease
por: Kim, Gheun-Ho
Publicado: (2019)

The Role of V2 Receptor Antagonists in the Treatment of Hyponatremia
por: Palmer, Biff F.
Publicado: (2013)

Predictors of cardio-kidney complications and treatment failure in patients with chronic kidney disease and type 2 diabetes treated with SGLT2 inhibitors
por: Kovesdy, Csaba, et al.
Publicado: (2022)

Hyperkalemia in patients undergoing hemodialysis: Its pathophysiology and management
por: Shibata, Shigeru, et al.
Publicado: (2021)

Stress-Dose Steroids: A Potential Therapeutic Option for Refractory Hyperkalemia
por: Zardoost, Pooya, et al.
Publicado: (2023)

Amlodipine in the current management of hypertension
por: Wang, Ji‐Guang, et al.
Publicado: (2023)

High unmet treatment needs in patients with chronic kidney disease and type 2 diabetes: real-world evidence from a US claims database
por: Fried, Linda, et al.
Publicado: (2022)

Heparin‐induced hyperkalemia, can LMWH cause hyperkalemia? A systematic review
por: Amdetsion, Gedion Yilma, et al.
Publicado: (2023)

Annual health care resource utilization and cost among type 2 diabetes patients with newly recognized chronic kidney disease within a large U.S. administrative claims database
por: Folkerts, Kerstin, et al.
Publicado: (2020)

Hyperkalemia in chronic peritoneal dialysis patients
por: Elliott, Andrew B., et al.
Publicado: (2022)

Managing Hyperkalemia in the Modern Era: A Case-Based Approach
por: Massicotte-Azarniouch, David, et al.
Publicado: (2023)

Management of hyperkalemia in chronic heart failure using sodium zirconium cyclosilicate
por: Oshima, Akira, et al.
Publicado: (2021)

Hyperkalemia in Diabetes Mellitus Setting
por: Goia-Nishide, Kleber, et al.
Publicado: (2022)

Acute hyperkalemia in adults
por: Emektar, Emine
Publicado: (2023)

Understanding and Treatment Strategies of Hypertension and Hyperkalemia in Chronic Kidney Disease
por: Jo, Sang Min
Publicado: (2023)

Chronic kidney disease progression among patients with type 2 diabetes identified in US administrative claims: a population cohort study
por: Kovesdy, Csaba P, et al.
Publicado: (2020)

Chronic hyperkalemia in non-dialysis CKD: controversial issues in nephrology practice
por: De Nicola, Luca, et al.
Publicado: (2018)

Determinants of Hyperkalemia Progression Among Patients with Mild Hyperkalemia
por: Israni, Rubeen, et al.
Publicado: (2021)

Treatment and pathogenesis of acute hyperkalemia
por: Mushiyakh, Yelena, et al.
Publicado: (2012)

Chronic renal failure, hyperkalemia, and colonic ulcers
por: George, S. A., et al.
Publicado: (2014)

Hyperkalemia in heart failure: Foe or friend?
por: Rakisheva, Amina, et al.
Publicado: (2020)

Hyperkalemia: pathophysiology, risk factors and consequences
por: Hunter, Robert W, et al.
Publicado: (2019)

Hyperkalemia: Prevalence, Predictors and Emerging Treatments
por: Larivée, Natasha L., et al.
Publicado: (2022)

Hyperkalemia and Rhabdomyolyssis
por: Yasri, Sora, et al.
Publicado: (2015)

Propranolol-induced hyperkalemia in the management of infantile hemangioma
por: Al-Rwebah, Huda, et al.
Publicado: (2020)

Inpatient management and post-discharge outcomes of hyperkalemia
por: Davis, Jill, et al.
Publicado: (2021)

Prevalence and management of hyperkalemia in chronic kidney disease and heart failure patients in the Gulf Cooperation Council (GCC)
por: AlSahow, Ali, et al.
Publicado: (2023)

Hemodialysis treatment in patients with severe electrolyte disorders: Management of hyperkalemia and hyponatremia
por: Pirklbauer, Markus
Publicado: (2020)

Prevention and management of hyperkalemia in patients treated with renin–angiotensin–aldosterone system inhibitors
por: Weinstein, Jordan, et al.
Publicado: (2021)

Effect of Sodium Zirconium Cyclosilicate on Serum Potassium and Bicarbonate in Patients with Hyperkalemia and Metabolic Acidosis Associated with Chronic Kidney Disease: Rationale and Design of the NEUTRALIZE Study
por: Ash, Stephen R., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fb2tk6kc5j5cqp5n2d7e8iapsj